Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Benzopyran. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113087691A details a Pd-catalyzed kinetic resolution for chiral aryl tertiary alcohols. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Discover the advanced synthesis of 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid via patent CN1629154A, offering cost-effective and high-purity pharmaceutical intermediates.
Patent CN104860915B reveals water-based synthesis for 4H-4-arylbenzopyran intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable green chemistry.
Discover a novel Brønsted acid-catalyzed synthesis for benzopyran derivatives. This patent-backed route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN116041358A introduces a mild sulfonation activation method for Pranoprofen, eliminating harsh cryogenic conditions and reducing difficult alkene impurities for cost-effective manufacturing.
Patent CN113979983A reveals a high-efficiency Rh-catalyzed hydrogenation route for Fidarestat intermediates, offering superior enantioselectivity and cost reduction for pharmaceutical manufacturing.
Advanced synthesis of benzopyran derivatives for inflammation treatment. Patent CN1041311C offers cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN116396330A discloses a stable synthesis route for CRAC inhibitors, offering improved purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN100434427C reveals efficient acid-catalyzed route. High yields, recyclable catalyst. Ideal for pharma R&D and supply chain optimization.
Patent CN102424675B details a mild, high-yield route for 2-amino-3-cyano benzopyran derivatives, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN112939993B9 reveals novel benzopyran derivatives enhancing OLED efficiency and lifespan. Discover scalable synthesis routes and supply chain advantages for electronic chemical manufacturing.
Patent CN102250050B reveals a novel synthesis route for 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid, eliminating expensive Pd/C catalysts for cost-effective API manufacturing.
Patent CN105837544B details a rare earth catalyzed synthesis offering high purity and environmental safety for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105837544B details a green synthesis route for coumarin derivatives using rare earth catalysts, offering supply chain stability and cost efficiency.
This patent reveals a base-catalyzed route for benzopyran synthesis offering high yields and mild conditions suitable for scalable pharmaceutical intermediate manufacturing processes globally.
Patent CN104610216B reveals a one-pot cascade synthesis for 6H-benzo[C]benzopyrans. This method offers significant supply chain and cost advantages for pharmaceutical intermediates.
Novel patent CN118724858B reveals high-yield synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing for global buyers.
Patent CN113214205B details a high-yield copper-catalyzed route for chromone derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN101679407B details a scalable route for benzopyran-2-one derivatives, offering cost-effective API intermediate manufacturing without chromatography.
Novel Cu-catalyzed one-step synthesis of 3-sulfonyl-2H-benzopyran derivatives. High purity, mild conditions, scalable for pharmaceutical intermediate manufacturing.